CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: thiram
Accession: CHEBI:9495
browse the term
Definition: An organic disulfide that results from the formal oxidative dimerisation of N,N-dimethyldithiocarbamic acid. It is widely used as a fungicidal seed treatment.
Synonyms: exact_synonym: [disulfanediylbis(carbonothioylnitrilo)]tetramethane
related_synonym: Arasan; Bis(dimethyl-thiocarbamoyl)-disulfid; Formula=C6H12N2S4; InChI=1S/C6H12N2S4/c1-7(2)5(9)11-12-6(10)8(3)4/h1-4H3; InChIKey=KUAZQDVKQLNFPE-UHFFFAOYSA-N; N(1),N(1),N(3),N(3)-tetramethyl-2-dithioperoxy-1,3-dithiodicarbonic diamide; N,N'-(dithiodicarbonothioyl)bis(N-methylmethanamine); N,N-tetramethylthiuram disulfide; Nomersan; Pomarsol; Rezifilm; SMILES=CN(C)C(=S)SSC(=S)N(C)C; TMTD; Tetramethyl-thiram disulfid; Tetramethylthioperoxydicarbonic diamide; [Me2NC(S)S]2; alpha,alpha'-dithiobis(dimethylthio)formamide; bis((dimethylamino)carbonothioyl) disulfide; bis(dimethyl thiocarbamoyl)disulfide; bis(dimethylthiocarbamoyl) disulfide; disulfure de tetramethylthiourame; tetramethylenethiuram disulfide; tetramethylthiuram disulfide; tetramethylthiurane disulfide; tetrathiuram disulfide; thirame; thiramum; thiuram; tiramo
xref: CAS:137-26-8; Drug_Central:3601; KEGG:C11160; KEGG:D06114
xref_mesh: MESH:D013893
xref: PMID:14587840; PMID:1842585; PMID:20940038; PMID:3055654; PMID:3176026; PPDB:642; Pesticides:thiram; Reaxys:1725821; Wikipedia:Thiram
G
AKR1C2
aldo-keto reductase family 1 member C2
increases activity
EXP
Thiram results in increased activity of AKR1C2 promoter
CTD
PMID:21195160
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
G
AMPD3
adenosine monophosphate deaminase 3
increases expression
EXP
Thiram results in increased expression of AMPD3 mRNA
CTD
PMID:24211530
NCBI chr11:10,450,388...10,507,579
Ensembl chr11:10,308,313...10,507,579
G
ANXA10
annexin A10
increases expression
EXP
Thiram results in increased expression of ANXA10 mRNA
CTD
PMID:32194361
NCBI chr 4:168,092,537...168,187,736
Ensembl chr 4:168,092,537...168,187,736
G
ARG1
arginase 1
decreases expression
EXP
Thiram results in decreased expression of ARG1 mRNA
CTD
PMID:32194361
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
G
ATF3
activating transcription factor 3
increases expression
EXP
Thiram results in increased expression of ATF3 mRNA
CTD
PMID:23999411 PMID:27965148
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
CASP1
caspase 1
affects expression
ISO
Thiram affects the expression of CASP1 protein
CTD
PMID:25929180
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CCR2
C-C motif chemokine receptor 2
decreases expression
EXP
Thiram results in decreased expression of CCR2 mRNA
CTD
PMID:19371601
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CD86
CD86 molecule
increases expression
EXP
Thiram results in increased expression of CD86 protein
CTD
PMID:19665512
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CREB1
cAMP responsive element binding protein 1
increases expression
EXP
Thiram results in increased expression of CREB1 mRNA
CTD
PMID:20385217
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CREM
cAMP responsive element modulator
increases expression
EXP
Thiram results in increased expression of CREM mRNA
CTD
PMID:19371601
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression increases secretion multiple interactions
EXP
Thiram results in increased expression of CXCL8 mRNA Thiram results in increased secretion of CXCL8 protein SB 203580 affects the reaction [Thiram results in increased secretion of CXCL8 protein]
CTD
PMID:18494145 PMID:19878716 PMID:21920952 PMID:27965148
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
increases expression
EXP
Thiram results in increased expression of CYP1A1 mRNA; Thiram results in increased expression of CYP1A1 protein
CTD
PMID:32194361
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
decreases expression
EXP
Thiram results in decreased expression of CYP2C19 protein
CTD
PMID:32194361
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
increases metabolic processing multiple interactions
ISO
CYP2E1 protein results in increased metabolism of Thiram Thiram inhibits the reaction [Isoniazid results in increased activity of CYP2E1 protein]
CTD
PMID:12458634
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
decreases expression
EXP
Thiram results in decreased expression of CYP7A1 mRNA
CTD
PMID:32194361
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
DNAJB4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
EXP
Thiram results in increased expression of DNAJB4 mRNA
CTD
PMID:23999411 PMID:27965148
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
G
FTH1
ferritin heavy chain 1
increases expression
EXP
Thiram results in increased expression of FTH1 mRNA
CTD
PMID:24211530
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FTL
ferritin light chain
increases expression
EXP
Thiram results in increased expression of FTL mRNA
CTD
PMID:24211530
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
Thiram results in decreased expression of G6PC1 mRNA
CTD
PMID:32194361
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
Thiram results in increased expression of GCLM mRNA
CTD
PMID:23999411 PMID:24211530 PMID:27965148
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
HMOX1
heme oxygenase 1
increases expression
ISO EXP
Thiram results in increased expression of HMOX1 mRNA
CTD
PMID:23445166 PMID:24211530
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
multiple interactions decreases activity
EXP
Dithiothreitol inhibits the reaction [Thiram results in decreased activity of HSD11B2 protein]; Ethylmaleimide promotes the reaction [Thiram results in decreased activity of HSD11B2 protein]; Thiram inhibits the reaction [HSD11B2 protein results in increased oxidation of Dexamethasone]
CTD
PMID:12901862 PMID:16857225 PMID:22796344
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
HSD3B1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
decreases activity multiple interactions
EXP
Thiram results in decreased activity of HSD3B1 protein Dithiothreitol inhibits the reaction [Thiram results in decreased activity of HSD3B1 protein]
CTD
PMID:36965607
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
G
HSPA6
heat shock protein family A (Hsp70) member 6
increases expression
EXP
Thiram results in increased expression of HSPA6 mRNA
CTD
PMID:23999411
NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894
G
ICAM1
intercellular adhesion molecule 1
multiple interactions increases expression
EXP
Thiram promotes the reaction [TNF protein results in increased expression of ICAM1 protein] Thiram results in increased expression of ICAM1 protein
CTD
PMID:25752435
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNG
interferon gamma
increases expression
ISO
Thiram results in increased expression of IFNG protein
CTD
PMID:12062936
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL18
interleukin 18
increases expression
EXP
Thiram results in increased expression of IL18 protein
CTD
PMID:23063874
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1A
interleukin 1 alpha
increases expression
EXP
Thiram results in increased expression of IL1A mRNA
CTD
PMID:33715048
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
increases secretion
EXP
Thiram results in increased secretion of IL1B protein
CTD
PMID:33715048
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL4
interleukin 4
increases expression
ISO
Thiram results in increased expression of IL4 protein
CTD
PMID:12062936
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
LEP
leptin
multiple interactions
ISO
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of LEP protein
CTD
PMID:29321614
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LEPR
leptin receptor
multiple interactions
ISO
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of LEPR mRNA
CTD
PMID:29321614
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
MT1G
metallothionein 1G
increases expression
EXP
Thiram results in increased expression of MT1G mRNA
CTD
PMID:32870474
NCBI chr16:56,666,730...56,668,065
Ensembl chr16:56,666,730...56,668,065
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression
EXP
Thiram results in increased expression of MYC mRNA
CTD
PMID:24211530
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
NAMPT
nicotinamide phosphoribosyltransferase
increases expression
EXP
Thiram results in increased expression of NAMPT mRNA
CTD
PMID:19371601
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
G
NFKB1
nuclear factor kappa B subunit 1
decreases expression
EXP
Thiram results in decreased expression of NFKB1 mRNA
CTD
PMID:20385217
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NLRP3
NLR family pyrin domain containing 3
affects expression
ISO
Thiram affects the expression of NLRP3 protein
CTD
PMID:25929180
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
G
NMB
neuromedin B
multiple interactions
ISO
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of NMB mRNA
CTD
PMID:29321614
NCBI chr15:84,655,132...84,658,199
Ensembl chr15:84,655,129...84,658,563
G
NMBR
neuromedin B receptor
multiple interactions
ISO
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NMBR mRNA
CTD
PMID:29321614
NCBI chr 6:142,074,484...142,147,122
Ensembl chr 6:142,058,330...142,147,122
G
NPY1R
neuropeptide Y receptor Y1
multiple interactions
ISO
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NPY1R mRNA
CTD
PMID:29321614
NCBI chr 4:163,323,962...163,344,689
Ensembl chr 4:163,323,962...163,344,832
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Thiram results in increased expression of NQO1 mRNA
CTD
PMID:24211530
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR3C1
nuclear receptor subfamily 3 group C member 1
multiple interactions
EXP
Dithiothreitol inhibits the reaction [Thiram inhibits the reaction [Dexamethasone binds to NR3C1 protein]]; Thiram inhibits the reaction [Dexamethasone binds to NR3C1 protein]; Thiram inhibits the reaction [Hydrocortisone binds to NR3C1 protein]
CTD
PMID:16857225
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
PARK7
Parkinsonism associated deglycase
decreases activity
EXP
Thiram results in decreased activity of PARK7 protein
CTD
PMID:36842454
NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505
G
PECAM1
platelet and endothelial cell adhesion molecule 1
multiple interactions
EXP
Thiram inhibits the reaction [TNF protein results in decreased expression of PECAM1 protein]
CTD
PMID:25752435
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PRKCA
protein kinase C alpha
decreases activity
EXP
Thiram results in decreased activity of PRKCA protein
CTD
PMID:15998240
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
G
PRKCB
protein kinase C beta
decreases activity
EXP
Thiram results in decreased activity of PRKCB protein
CTD
PMID:15998240
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
G
PRKCD
protein kinase C delta
increases activity
EXP
Thiram results in increased activity of PRKCD protein
CTD
PMID:15998240
NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
G
PRKCE
protein kinase C epsilon
decreases activity
EXP
Thiram results in decreased activity of PRKCE protein
CTD
PMID:15998240
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
G
PRKCG
protein kinase C gamma
decreases activity
EXP
Thiram results in decreased activity of PRKCG protein
CTD
PMID:15998240
NCBI chr19:53,881,094...53,907,652
Ensembl chr19:53,879,190...53,907,652
G
PTGS2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Thiram results in increased expression of PTGS2 mRNA
CTD
PMID:19371601
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
S100P
S100 calcium binding protein P
increases expression
EXP
Thiram results in increased expression of S100P protein
CTD
PMID:32194361
NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170
G
SEL1L3
SEL1L family member 3
increases expression
EXP
Thiram results in increased expression of SEL1L3 mRNA
CTD
PMID:24211530
NCBI chr 4:25,713,964...25,863,566
Ensembl chr 4:25,747,433...25,863,760
G
SFTPA1
surfactant protein A1
multiple interactions
EXP
Thiram inhibits the reaction [Dexamethasone results in decreased expression of SFTPA1 mRNA]
CTD
PMID:16857225
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SFTPB
surfactant protein B
multiple interactions
EXP
Thiram inhibits the reaction [Dexamethasone results in increased expression of SFTPB mRNA]
CTD
PMID:16857225
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
G
SLC7A11
solute carrier family 7 member 11
increases expression
EXP
Thiram results in increased expression of SLC7A11 mRNA
CTD
PMID:24211530
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SQSTM1
sequestosome 1
increases expression
EXP
Thiram results in increased expression of SQSTM1 mRNA
CTD
PMID:24211530
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
SYNE2
spectrin repeat containing nuclear envelope protein 2
decreases expression
EXP
Thiram results in decreased expression of SYNE2 mRNA
CTD
PMID:24211530
NCBI chr14:63,761,596...64,226,449
Ensembl chr14:63,761,899...64,226,433
G
TGFB1
transforming growth factor beta 1
decreases activity
EXP
Thiram results in decreased activity of TGFB1 protein
CTD
PMID:31652400
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TNF
tumor necrosis factor
increases expression multiple interactions
EXP
Thiram results in increased expression of TNF mRNA Thiram inhibits the reaction [TNF protein results in decreased expression of PECAM1 protein]; Thiram inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Thiram promotes the reaction [TNF protein results in increased expression of ICAM1 protein]
CTD
PMID:20385217 PMID:25752435
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNNT2
troponin T2, cardiac type
decreases expression
EXP
Thiram results in decreased expression of TNNT2 mRNA
CTD
PMID:24211530
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
G
TRIM16L
tripartite motif containing 16 like (pseudogene)
increases expression
EXP
Thiram results in increased expression of TRIM16L mRNA
CTD
PMID:24211530
NCBI chr17:18,697,998...18,736,112
Ensembl chr17:18,722,237...18,735,460 Ensembl chr17:18,722,237...18,735,460
G
TXNRD1
thioredoxin reductase 1
increases expression
ISO EXP
Thiram results in increased expression of TXNRD1 mRNA
CTD
PMID:23445166 PMID:24211530
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
UBA1
ubiquitin like modifier activating enzyme 1
multiple interactions
EXP
Thiram results in decreased activity of and results in decreased ubiquitination of UBA1 protein
CTD
PMID:25714994
NCBI chr X:47,190,847...47,215,128
Ensembl chr X:47,190,861...47,215,128
G
VCAM1
vascular cell adhesion molecule 1
multiple interactions
EXP
Thiram inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]
CTD
PMID:25752435
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all